Continued Advancement of Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) - Final Analysis upon Reaching 80 ...
You will be redirected to our submission process. Multi-omics studies now span genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiomics, and spatial and single-cell modalities, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results